Anti-Xa stability of diluted enoxaparin for use in pediatrics.
about
Effects of age and weight-based dosing of enoxaparin on anti-factor xa levels in pediatric patients.Stability and Sterility of Enoxaparin 8 mg/mL Subcutaneous Injectable Solution.Stability of plasma anti-Xa activity in low-molecular-weight heparin monitoring.Anti-Xa stability of diluted dalteparin for pediatric use.
P2860
Anti-Xa stability of diluted enoxaparin for use in pediatrics.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Anti-Xa stability of diluted enoxaparin for use in pediatrics.
@en
Anti-Xa stability of diluted enoxaparin for use in pediatrics.
@nl
type
label
Anti-Xa stability of diluted enoxaparin for use in pediatrics.
@en
Anti-Xa stability of diluted enoxaparin for use in pediatrics.
@nl
prefLabel
Anti-Xa stability of diluted enoxaparin for use in pediatrics.
@en
Anti-Xa stability of diluted enoxaparin for use in pediatrics.
@nl
P2093
P2860
P356
P1476
Anti-Xa stability of diluted enoxaparin for use in pediatrics.
@en
P2093
Cinda L Christensen
Edward C Larkin
Jeffery H King
John T Owings
Robert C Gosselin
William E Dager
P2860
P304
P356
10.1345/APH.1D107
P407
P577
2004-02-24T00:00:00Z